Literature DB >> 12172395

Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples.

Charles M Strom1, Donghui Huang, Arlene Buller, Joy Redman, Beryl Crossley, Ben Anderson, Tom Entwistle, Weimin Sun.   

Abstract

PURPOSE: To determine the accuracy of two commercially available kits for cystic fibrosis (CF) genotyping and determine allele frequencies for the ACMG/ACOG recommended mutations.
METHODS: A total of 1,040 consecutive analyses using Roche CF Gold Strips and the ABI CF Genotyper were performed. Subsequently we performed analyses of 20,103 samples.
RESULTS: Both kits accurately determined CF genotypes. The I148T mutation was found >100 times more frequently in carrier screening than in CF patients. Asymptomatic patients were identified who are compound heterozygotes for delta F508 and I148T. Four of 13 patients heterozygous for delta F508 and the IVS8-5T polymorphism had some symptoms of CF.
CONCLUSION: Accurate and timely analysis can be performed for the ACMG CF panel. I148T is a low penetrance CF allele.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172395     DOI: 10.1097/00125817-200207000-00007

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  11 in total

1.  Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms.

Authors:  Andrew G Hadd; Walairat Laosinchai-Wolf; Chris R Novak; Marty R Badgett; Lesley A Isgur; Marianna Goldrick; Cindy R Walkerpeach
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

2.  Detection of an apparent homozygous 3120G>A cystic fibrosis mutation on a routine carrier screen.

Authors:  Denise LaMarche Heaney; Patrick Flume; Lauren Hamilton; Elaine Lyon; Daynna J Wolff
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

3.  Identification of cystic fibrosis variants by polymerase chain reaction/oligonucleotide ligation assay.

Authors:  Karen M Schwartz; Lisa L Pike-Buchanan; Kasinathan Muralidharan; Joy B Redman; Jean Amos Wilson; Michael Jarvis; M Grace Cura; Victoria M Pratt
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

4.  Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening.

Authors:  Feras M Hantash; Joy B Redman; Kelsey Starn; Ben Anderson; Arlene Buller; Matthew J McGinniss; Franklin Quan; Mei Peng; Weimin Sun; Charles M Strom
Journal:  Hum Genet       Date:  2005-12-17       Impact factor: 4.132

5.  Technical validation of a TM Biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel.

Authors:  Charles M Strom; Richard Janeszco; Franklin Quan; Sheng-biao Wang; Arlene Buller; Matthew McGinniss; Weimin Sun
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

6.  Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Elinor Langfelder-Schwind; Edward Kloza; Elaine Sugarman; Barbara Pettersen; Trisha Brown; Kim Jensen; Seth Marcus; Joy Redman
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

7.  Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

Authors:  Joshua D Groman; Timothy W Hefferon; Teresa Casals; Lluís Bassas; Xavier Estivill; Marie Des Georges; Caroline Guittard; Monika Koudova; M Daniele Fallin; Krisztina Nemeth; Gyorgy Fekete; Ludovit Kadasi; Ken Friedman; Martin Schwarz; Cristina Bombieri; Pier Franco Pignatti; Emmanuel Kanavakis; Maria Tzetis; Marianne Schwartz; Giuseppe Novelli; Maria Rosaria D'Apice; Agnieszka Sobczynska-Tomaszewska; Jerzy Bal; Manfred Stuhrmann; Milan Macek; Mireille Claustres; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

8.  Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.

Authors:  Michael S Watson; Garry R Cutting; Robert J Desnick; Deborah A Driscoll; Katherine Klinger; Michael Mennuti; Glenn E Palomaki; Bradley W Popovich; Victoria M Pratt; Elizabeth M Rohlfs; Charles M Strom; C Sue Richards; David R Witt; Wayne W Grody
Journal:  Genet Med       Date:  2004 Sep-Oct       Impact factor: 8.822

9.  Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations?

Authors:  Mireille Claustres; Jean-Pierre Altiéri; Caroline Guittard; Carine Templin; Françoise Chevalier-Porst; Marie Des Georges
Journal:  BMC Med Genet       Date:  2004-08-02       Impact factor: 2.103

10.  It's complicated: criteria for policy decisions for the clinical integration of genome-scale sequencing for reproductive decision making.

Authors:  Benjamin S Wilfond; Katrina Ab Goddard
Journal:  Mol Genet Genomic Med       Date:  2015-07       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.